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Supplemental Films. 
Video 1: Non- treated CatSper KO sperm.  
Video 2: A23187 treated CatSper KO sperm. 
Video 3: Non- treated Slo3 KO sperm. 
Video 4: A23187 treated Slo3 KO sperm. 
Video 5: Non- treated Adcy10 KO sperm. 




































In all supplementary tables, data were obtained as described in Methods using the 
CEROS computer-assisted semen analysis (CASA) system (Hamilton Thorne 
Research, Beverly, MA) as previously described1. The default settings include the 
following: frames acquired: 90; frame rate: 60 Hz; minimum cell size: 4 pixels; static 
head size: 0.13-2.43; static head intensity: 0.10-1.52; static head elongation: 5-100. 
Sperm with hyper activated motility, defined as motility with high amplitude thrashing 
patterns and short distance of travel, were sorted and analyzed using the CASAnova 
software2. At least 20 microscopy fields corresponding to a minimum of 200 sperm 
were analyzed in each experiment. Values are means ± S.E.M obtained with sperm 
from n number of individual mice as indicated in the respective table below. Parameter 
percentages are obtained considering only motile sperm. VAP, average path velocity 
in µm/sec; VSL, straight line velocity in µm/sec; VCL, curvilinear velocity in µm/sec; 
ALH, amplitude of lateral head displacement in µm; BCF, beat cross frequency in Hz.  
  
Supplementary Table I. CASANova analyses of sperm motility from CD1 and C57BL/6J 
mice strains incubated or not for 10 minutes with 20 µM A23187 as described in Methods. 
 
1-) CD-1 (ICR) sperm without A23187 treatment (n = 4) 
 
Total Motility  69% ± 0.115 
 VAP VSL VCL ALH BCF % 
Weak 37.30 ± 2.8 12.45 ± 0.1 80.78 ± 6.7 7.470 ± 0.5 39.38 ± 1.4 24 
Slow 95.40 ± 3.3 40.17 ± 4.4 173.8 ± 8.5 12.89 ± 0.4 29.77 ± 1.1 15 
Intermediate  190.1 ± 8.7 123.2 ± 2.9 376.3 ± 10.8 20.19 ± 3.1 17.88 ± 3.9 3 
Progressive 152.4 ± 7.5 115.1 ± 8.9 256.2 ± 3.2 15.50 ± 0.4 24.72 ± 0.9 38 
Hyperactive  154.8 ± 4.8 50.37 ± 4.6 291.1 ± 3.2 19.18 ± 0.4 31.16 ± 0.5 20 
 
2-) CD-1 (ICR) sperm with A23187 treatment (n = 4) 
 
Total Motility 72% ± 1.2 
 VAP VSL VCL ALH BCF  
Weak 42.47 ± 4.1 15.48 ± 2.1 99.63 ± 10 9.66 ± 1.4 40.00 ± 1.5 22 
Slow 93.92 ± 2.1 40.99 ± 5.7 179.8 ± 9.7 12.9 ± 0.6 28.46 ± 0.4 15 
Intermediate  142.8 ± 9.4 93.55 ± 9.8 312.5 ± 15 20.25 ± 2.1 21.92 ± 5.6 4 
Progressive 145.6 ± 10 117.6 ± 11 236.0 ± 14 12.31 ± 1.3 21.90 ± 2.1 35 
Hyperactive  170.3 ± 10 63.94 ± 8.1 352.4 ± 29 21.25 ± 1.5 29.76 ± 1.9 24 
 
3-) C57BL/6J sperm without A23187 treatment (n = 4)  
 
Total Motility 53% ± 2.3  
Group VAP VSL VCL ALH BCF %  
Weak 37.63 ± 0.2 13.14 ± 0.3 90.43 ± 0.8 8.085 ± 0.01 43.74 ± 0.8 41 
Slow 87.97 ± 3.2 44.48 ± 0.4 170.5 ± 3.5 13.28 ± 0.2 27.28 ± 1.0 13 
Intermediate  168.3 ± 7.2 122.5 ± 2.5 344.8 ± 4.7  16.37 ± 1.6 19.47 ± 6.1 2 
Progressive 126.5 ± 8.3 349.7 ± 0.3 140.5 ± 38.8 12.78 ± 1.9 28.70 ± 5.8 37 
Hyperactive  149.3 ± 3.4 53.76 ± 2.5 302.3 ± 9.2 20.73 ± 0.66 32.13 ± 0.2 8 
 
4-) C57BL/6J sperm with A23187 treatment (n = 4) 
 
Total Motility 67% ± 1.8  
     Group VAP VSL VCL ALH BCF % 
Weak 34.61 ± 0.7 13.32 ± 0.1 79.52 ± 6.1 6.57 ± 1.1 41.33 ± 1.1 28 
Slow 93.34 ± 1.1 43.29 ± 0.3 183.3 ± 1.2 13.72 ± 0.1 30.66 ± 0.9 9 
Intermediate  180.5 ± 0.8 114.1 ± 1.8 350.5 ± 5.4 21.16 ± 1.2 24.75 ± 2.2 3 
Progressive 150.9 ± 5.1 123.6 ± 4.1 248.6 ± 2.2 15.42 ± 0.2 23.30 ± 0.1 42 





Supplementary Table II. CASANova analyses of sperm motility from CatSper KO mice 
strains incubated or not for 10 minutes with 20 µM A23187 as described in Methods. 
 
 
1-) C57BL/6J CatSper KO sperm without A23187 treatment (n = 7)  
 
Total Motility	 47%	± 3.9	
     Group	 VAP	 VSL	 VCL	 ALH	 BCF	 %	
Weak	 50.72 ± 2.2 13.90 ± 0.6 117.2 ± 0.8 9.44 ± 9.4 40.30 ± 40 56.7	
Slow	 76.83 ± 2 40.09 ± 4.6 150.5 ± 16 10.90 ± 10 27.62 ± 27 34	
Intermediate		 163.0 ± 28 106.9 ± 13 334.7 ± 23 19.91 ± 19 21.23 ± 21 1	
Progressive	 180.4 ± 16 152.7 ± 14 257.4 ± 25 15.70 ± 15 18.76 ± 18 8	
Hyperactive		 209.2 ± 17 54.79 ± 7.8 386.4 ± 3.6 22.29 ± 22 29.27 ± 29 0.3	
 
 
1-) C57BL/6J CatSper KO sperm with A23187 treatment (n = 7) 
 
Total Motility	 64%	± 4.5		
	 VAP	 VSL	 VCL	 ALH	 BCF	 %	
Weak	 39.26 ± 5.4  12.88 ± 1.3 92.53 ± 10 8.27 ± 0.9 41.88 ± 1.8 38 
Slow	 85.92 ± 3.1 41.25 ± 4.1 167.0 ± 13 12.06 ± 0.6 32.08 ± 2.2 26 
Intermediate		 228.0 ± 28 157.6 ± 28 371.9 ± 0.1 21.50 ± 5.2 21.93 ± 4.2 3 
Progressive	 157.9 ± 5 128.2 ± 2.5 244.1 ± 7.7 13.79 ± 0.7 24.61 ± 0.0 21 



























Supplementary Table III. CASANova analyses of sperm motility from wild type C57BL/6J, 
SLO3 KO and Adcy10 (aka sAC) KO mice incubated or not for 10 minutes with 20 µM 
A23187 as described in Methods. Note that data using sperm from C57BL/6J mice were 
done independently from the ones shown in Table I.  
 
 
1-) C57BL/6J sperm without A23187 treatment (n = 7) 
 
Total Motility 45% ± 2.2  
Group VAP VSL VCL ALH BCF %  
Weak 38.78 ± 0.3 14.05± 0.9 89.67 ± 1.1 10.0 ± 0.1 43.74 ± 0.8 48 
Slow 80.89 ± 2.2 45.67 ± 0.2 175.5 ± 2.5 14.45 ± 0.6 27.28 ± 1.0 14 
Intermediate  176.8 ± 4.2 125.5 ± 3.4 345.8 ± 3.7  17.37 ± 1.7 19.47 ± 6.1 2 
Progressive 116.4 ± 10 149.7 ± 0.5 135.5 ± 18.8 13.78 ± 2 28.70 ± 5.8 30 
Hyperactive  150.3 ± 3.9 51.45 ± 3.5 310.3 ± 7.2 22.73 ± 0.89 32.13 ± 0.2 7 
 
 
2-) C57BL/6J sperm with A23187 treatment (n = 7) 
 
Total Motility 52% ± 1.7  
     Group VAP VSL VCL ALH BCF % 
Weak 35.61 ± 0.5 14.42 ± 0.1 84.40 ± 7.3 7.58 ± 1.6 42.43 ± 2.1 28 
Slow 90.34 ± 1.5 44.29 ± 0.3 187.5 ± 1.5 13.88 ± 0.1 31.26 ± 0.7 9 
Intermediate  185.5 ± 0.4 119.1 ± 1.2 356.2 ± 4.4 21.16 ± 1.2 23.35 ± 1.5 3 
Progressive 155.9 ± 4.4 122.6 ± 2.1 147.7 ± 2.4 12.42 ± 0.6 25.30 ± 1.3 44 
Hyperactive  148.1 ± 3.5 57.04 ± 2.3 300.2 ± 8.3 21.89 ± 0.2 33.89 ± 0.3 16 
 
3-) C57BL/6J SLO3 KO sperm without A23187 treatment (n = 3) 
 
Total Motility 31% ± 8.8 
Group VAP VSL VCL ALH BCF % 
Weak 37.85 ± 2.7 13.40 ± 2.3  89.07 ± 8.6 7.51  ± 0.2 34.72 ± 5.7 52 
Slow 70.10 ± 3.1 40.41 ± 6.0 146.0 ± 7.9 8.45  ± 2 24.94 ± 3.3 33 
Intermediate  0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00  ± 0 0.00   ± 0 0 
Progressive 176.5 ± 20.8 150.0 ± 29 272.6 ± 5 14.9  ± 0.8 13.45 ± 13 15 
Hyperactive  0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00  ± 0 0.00   ± 0  0 
 
4-) C57BL/6J SLO3 KO sperm with A23187 treatment (n = 3)  
 
Total Motility 47% ± 7.2  
Group VAP VSL VCL ALH BCF % 
Weak 37.63 ± 1.8 13.21 ± 0.5 80.94 ± 10 5.80  ± 1.4 41.43 ± 5.6 49 
Slow 84.20 ± 3.4 42.27 ± 0.1 159.5 ± 7.7 11.18 ± 0.0 24.08 ± 0.3 30 
Intermediate  163.7 ± 29 96.61 ± 26 321.9 ± 63 16.51 ± 3.4 12.70 ± 12 1 
Progressive 157.1 ± 13 132.8 ± 20 256.3 ± 19 13.00 ± 0.0 19.27 ± 4.9 11 
Hyperactive  143.9 ± 4 59.90 ± 5.5 312.5 ± 36 18.14 ± 2 29.86 ± 2 10 
 
 
5-) C57BL/6J SAC1 KO sperm without A23187 treatment (n = 4) 
 
Total Motility 2% ± 0.23  
Group VAP VSL VCL ALH BCF % 
Weak 28.10 ± 0.3 8.88  ± 0.8 74.98 ± 6.9 4.46 ± 0.6 30.71 ± 7.5 52 
Slow 81.36 ± 9.9 52.38 ± 3.4 137.1 ± 31 5.61 ± 1.1 6.40   ± 6.4 48 
Intermediate  0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0 
Progressive 0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0 
Hyperactive  0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0.00   ± 0 0 
 
6-) C57BL/6J SAC1 KO sperm with A23187 treatment (n = 4) 
 
Total Motility 31% ± 4.1  
Group VAP VSL VCL ALH BCF % 
Weak 36.18 ± 1.8 12.23 ± 0.2 104.9 ± 2.9 9.16   ± 0.2 45.29 ± 2.3 39 
Slow 76.82 ± 2.3 42.34 ± 9.1 169.3 ± 14 13.03 ± 0.3 31.78 ± 1.2 32 
Intermediate  221.4 ± 33 157.6 ± 5.9 471.2 ± 8.8 23.12 ± 0.0 17.07 ± 1.6 2 
Progressive 173.6 ± 17 148.0 ± 12 253.5 ± 21 14.48 ± 0.2 16.93 ± 5.2 20 
Hyperactive  152.5 ± 6.9 56.33 ± 1.2 399.6 ± 12 23.31 ± 1.1 40.20 ± 1.2 7 
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